Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study

NCT00302770 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00302770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2006
Completion date
December 31, 2006
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder